Ischemic stroke represents 87% of all strokes. 1 As world-wide initiatives move forward with
stroke care, healthcare providers and institutions will be called on to deliver the most current …

Network medicine utilizes common genetic origins, markers and co-morbidities to uncover
mechanistic links between diseases. These links can be summarized in the diseasome, a …

New Findings What is the central question of this study? Angiotensin‐(1–7) decreases
cerebral infarct volume and improves neurological function when delivered centrally before …

Hypertension is a major risk factor for stroke, which is one of the leading global causes of
death. In the search for new and effective therapeutic targets in stroke research, we need to …

Background and aims: Thrombolytic therapy with intravenous recombinant tissue
plasminogen activator (rt-PA) improves outcome in patients with ischaemic stroke treated …

Stroke is the leading cause of morbidity and mortality in diabetic patients. Diabetes alters the
endothelial function and disrupts brain pathways, resulting in a variety of systemic metabolic …

Background In acute ischemic stroke, a transient elevation of blood pressure is common; its
significance and its relationship with the neurological outcome are still unclear. Methods In …

Background Both type 2 diabetes mellitus (T2DM) and hypertension aggregate in families. It
is a common thought that diabetic patients with parental diabetes and/or parental …

Sari Kovats and Andrew Haines2 refer to “global average surface air temperature” and
“global average surface temperature” respectively. It appears that this is a key indicator upon …

Background: Stroke and transient ischemic attack (TIA) have a high personal and financial
cost to society and prevention is critical. Outside of registries in Ontario, there has been little …